https://www.prnewswire.com/news-releases/photocure-partner-asieris-announces-approval-to-conduct-a-phase-iii-clinical-trial-for-hexvix-in-china-301480521.html
/PRNewswire/ -- Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has obtained the Phase...
phase iiiphotocurepartnerannouncesapproval